G. Chittick

发表

Virus-Infected Pediatric Subjects Highly Active Antiretroviral Therapy Regimens in Human Immunodeficiency Long-term Safety and Efficacy Results of Once-Daily Emtricitabine-Based

R. Yogev, J. Hinkle, F. Rousseau, 2010 .

Long-term Safety and Efficacy Results of Once-Daily Emtricitabine-Based Highly Active Antiretroviral Therapy Regimens in Human Immunodeficiency Virus-Infected Pediatric Subjects

R. Yogev, J. Hinkle, F. Rousseau, 2008, Pediatrics.

Pharmacokinetic Interaction between Amprenavir and Rifabutin or Rifampin in Healthy Males

B. Sadler, D. Brophy, R. Polk, 2001, Antimicrobial Agents and Chemotherapy.

Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation.

Yeon Joo Lee, G. Papanicolaou, James W. Young, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pharmacokinetic Interaction of Abacavir (1592U89) and Ethanol in Human Immunodeficiency Virus-Infected Adults

D. Stein, G. Chittick, K. Edwards, 2000, Antimicrobial Agents and Chemotherapy.

Abacavir: Absolute Bioavailability, Bioequivalence of Three Oral Formulations, and Effect of Food

W. Prince, D. Stein, Y. Lou, 1999, Pharmacotherapy.

Pharmacokinetic Interaction between Ketoconazole and Amprenavir after Single Doses in Healthy Men

A. Pastor, B. Sadler, M. Crouch, 1999, Pharmacotherapy.

Short‐term clinical safety profile of brincidofovir: A favorable benefit–risk proposition in the treatment of smallpox

Marion E. Morrison, T. Brundage, G. Chittick, 2017, Antiviral research.

Pharmacokinetic Evaluation of Emtricitabine in Combination With Other Nucleoside Antivirals in Healthy Volunteers

G. Chittick, M. R. Blum, J. Hui, 2007, Journal of clinical pharmacology.

Pharmacokinetics of Tenofovir Disoproxil Fumarate and Ritonavir-Boosted Saquinavir Mesylate Administered Alone or in Combination at Steady State

B. Kearney, N. Adda, J. Sorbel, 2006, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic Interaction between Amprenavir and Clarithromycin in Healthy Male Volunteers

A. Pastor, B. Sadler, D. Brophy, 2000, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of [14C]Abacavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Inhibitor, Administered in a Single Oral Dose to HIV-1-Infected Adults: a Mass Balance Study

R. Polk, T. Kerkering, D. Stein, 1999, Antimicrobial Agents and Chemotherapy.

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

G. Papanicolaou, M. Boeckh, F. Marty, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Single-Dose Pharmacokinetics and Safety of Abacavir (1592U89), Zidovudine, and Lamivudine Administered Alone and in Combination in Adults with Human Immunodeficiency Virus Infection

G. Chittick, J. McDowell, Laureneh . Wang, 1999, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and Safety of Single Oral Doses of Emtricitabine in Human Immunodeficiency Virus-Infected Children

M. Rathore, P. Emmanuel, P. Flynn, 2004, Antimicrobial Agents and Chemotherapy.

Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.

J. Kurtzberg, J. Englund, Marion E. Morrison, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term Safety and Efficacy of a Once-Daily Regimen of Emtricitabine, Didanosine, and Efavirenz in HIV-Infected, Therapy-Naive Children and Adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021

M. Hughes, S. Spector, Chengcheng Hu, 2007, Pediatrics.

Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor, following Oral Administration of Single Doses to HIV-Infected Adults

B. Sadler, W. Symonds, N. Roskell, 1999, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate and tacrolimus at steady state when administered alone or in combination.

J. Sorbel, G. Chittick, M. R. Blum, 2008, International journal of clinical pharmacology and therapeutics.

Metabolic Disposition and Pharmacokinetics of [14C]‐Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV‐1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects

B. Sadler, R. Polk, T. Kerkering, 2001, Journal of clinical pharmacology.

Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial

Yusuke Suzuki, H. Iocca, S. Murray, 2020, Allergy.

Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial

G. Papanicolaou, T. Brundage, V. Prasad, 2017 .

The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).

P. Rolan, J. Posner, W. Leavens, 1997, British journal of clinical pharmacology.

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE ESCALATING ORAL DOSES OF GS-9620 IN HEALTHY SUBJECTS

B. Kearney, C. Frey, J. Findlay, 2011 .

Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection

T. Brundage, V. Prasad, H. Momméja-Marin, 2015 .

INDOOR ENVIRONMENT PROGRAM STAFF

M. Apte, D. Dumortier, W. Fisk, 2013 .

Single-Dose Pharmacokinetics and Safety of Abacavir (1592U89), Zidovudine, and Lamivudine Administered Alone and in Combination in Adults with Human Immunodeficiency Virus Infection

G. Chittick, J. McDowell, Laureneh . Wang, 1999, Antimicrobial Agents and Chemotherapy.

Steady‐State Pharmacokinetics of Emtricitabine and Tenofovir Disoproxil Fumarate Administered Alone and in Combination in Healthy Volunteers

G. Chittick, M. R. Blum, J. Zong, 2007, Journal of clinical pharmacology.

cmx001 is a potential treatment for Adenovirus infection: preliminary antiviral activity results from an open-label, expanded access study of Cmx001 for the treatment of serious or life-threatening diseases caused by doublestranded Dna viruses : o368

G. Papanicolaou, D. Margolskee, T. Brundage, 2013 .